Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and soman

2-chloro-n(6)cyclopentyladenosine has been researched along with soman in 2 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(soman)
Trials
(soman)
Recent Studies (post-2010) (soman)
2520431,3914257

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Langston, JL; Meads, KL; Myers, TM; Shih, TM; Thomas, TP1
Acon-Chen, C; Loughery, TN; Shih, TM; Whitten, KA1

Other Studies

2 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and soman

ArticleYear
Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against Soman intoxication in rats.
    Toxicology and applied pharmacology, 2021, 04-01, Volume: 416

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Behavior, Animal; Brain; Deoxyadenosines; Disease Models, Animal; Male; Neuroprotective Agents; Organophosphate Poisoning; Rats, Sprague-Dawley; Receptor, Adenosine A1; Seizures; Soman

2021
Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.
    Toxicology and applied pharmacology, 2021, 05-15, Volume: 419

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Brain; Deoxyadenosines; Disease Models, Animal; Drug Administration Schedule; Injections, Intramuscular; Male; Neuroprotective Agents; Norbornanes; Rats, Sprague-Dawley; Sarin; Soman; Status Epilepticus; Time Factors

2021